Most recently, it was shown that supplementation of CoQ10 could reduce myocardial injury by inhibiting p62 and increasing the expression of LC3 in the heart tissue of patients with hyperlipidemia [56]. The gene discussed is MAP1LC3A; the disease is hyperlipidemia.